Patents by Inventor Ohad BASHAN

Ohad BASHAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240100109
    Abstract: Botanical extracts are provided, which comprise ethanol extracts of Nannochloropsis algae having between 10 wt % and 50 wt % polar lipids and between 45 wt % and 60 wt % fatty acids, wherein the fatty acids comprise more than 10 wt % of eicosapentaenoic acid (EPA) as triglyceride conjugates and/or diglyceride conjugates, and less than 15 wt % EPA as free fatty acids. EPA level may reach up to 90 wt %, and the botanical extract may be fluid at room temperature. Growth conditions are configured, adjusted and monitored to promote EPA formation in the cell vacuoles, resulting in a high proportion of EPA as tri/di-glyceride conjugates, as well as in a high concentration of ?-3 fatty acids, which merely requires gentle extraction procedures to reach the final products, thereby maintaining the biochemical of the compounds without excessive modifications.
    Type: Application
    Filed: September 22, 2022
    Publication date: March 28, 2024
    Applicant: Vaxa Technologies Ltd.
    Inventors: Ohad BASHAN, Isaac BERZIN
  • Patent number: 11912966
    Abstract: Aspects of the invention are directed to a system and method of sparging an algae cultivation container. The method may include controlling at least one first sparger to distribute a first fluid into the container at a first operating flow rate; and controlling at least one second sparger to distribute a second fluid into the container at a second operating flow rate. The first operating flow rate may be adapted to allow mixing the algae in the cultivation container, and the second operating flow rate may be adapted to allow assimilation of materials in a liquid in the cultivation container.
    Type: Grant
    Filed: July 22, 2019
    Date of Patent: February 27, 2024
    Assignee: VAXA TECHNOLOGIES LTD
    Inventors: Oded Bashan, Ohad Bashan, Stephen Drummey
  • Patent number: 11883377
    Abstract: Botanical extracts are provided, which comprise ethanol extracts of Nannochloropsis algae having between 1 wt % and 50 wt % polar lipids and between 45 wt % and 60 wt % fatty acids, wherein the fatty acids comprise more than 10 wt % of eicosapentaenoic acid (EPA) as triglyceride conjugates and/or diglyceride conjugates, and less than 15 wt % EPA as free fatty acids. EPA level may reach up to 90 wt %, and the botanical extract may be fluid at room temperature. Growth conditions are configured, adjusted and monitored to promote EPA formation in the cell vacuoles, resulting in a high proportion of EPA as tri/di-glyceride conjugates, as well as in a high concentration of ?-3 fatty acids, which merely requires gentle extraction procedures to reach the final products, thereby maintaining the biochemical of the compounds without excessive modifications.
    Type: Grant
    Filed: November 25, 2022
    Date of Patent: January 30, 2024
    Assignee: VAXA TECHNOLOGIES LTD
    Inventors: Ohad Bashan, Isaac Berzin
  • Publication number: 20230190836
    Abstract: Spirulina extracts and/or fractionated compounds thereof, sublingual spray formulation thereof, spraying devices for using the formulation, as well as methods of preparing and using the spirulina extracts to treat TNF-? related inflammation are provided. The spirulina extracts are prepared by water extraction of Arthrospira spp. biomass that is cultivated under controlled, ultra-high-density conditions with strong UV illumination and strong continuous mixing, and are characterized by high levels of c-phycocyanin, sorbitol and adenosine derivates—which were found to have a strong low-dose effect of reducing TNF-? secretion. The spirulina extracts may correspondingly be used to prevent or alleviate cytokine storm related to various infections or autoimmune diseases.
    Type: Application
    Filed: May 19, 2021
    Publication date: June 22, 2023
    Applicant: Vaxa Technologies Ltd
    Inventors: Isaac BERZIN, Ohad BASHAN
  • Patent number: 11633135
    Abstract: A system for calibrating a device for measuring materials concentration in the blood is disclosed. The system may include at least two sets of calibrating elements, each set may include a plurality of calibrating elements. Each of the calibrating elements in the sets may include, a first layer simulating a specific human skin characteristics; and a second layer consisting a specific concentration of one or more materials in the blood. For all calibrating elements in a set the first layer may be the same first layer simulating the same human skin characteristics such that each set of calibrating elements simulate different skin characteristics. Each calibrating element in a set of calibrating elements may include a different second layer consisting a different concentration of the one or more materials. The system may further include a controller.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: April 25, 2023
    Assignee: WEAR2B LTD.
    Inventors: Ohad Bashan, Oded Bashan, Aharon Klein, Ben Zion Dekel, Giora Bar-Sakai
  • Patent number: 11629327
    Abstract: An algae cultivation system may include: a plurality of panels within a cultivation container, positioned along a first axis perpendicular to the gravitational force, wherein a cultivation volume is created between each pair of panels, and wherein the cultivation volumes are fluidly coupled so as to allow horizontal flow therebetween along the first axis; at least one first sparger, to distribute a first fluid into the container at a first operating flow rate; at least one second sparger, to distribute a second fluid into the container at a second operating flow rate; and at least one controller, to control the first operating flow rate and the second operating flow rate. The first operating flow rate may be adapted to allow turbulent mixing the algae in the cultivation container, and the second operating flow rate may be adapted to allow assimilation of materials in a liquid in the cultivation container.
    Type: Grant
    Filed: February 20, 2018
    Date of Patent: April 18, 2023
    Assignee: VAXA TECHNOLOGIES LTD
    Inventors: Ohad Bashan, Oded Bashan, Stephen Drummey
  • Publication number: 20220409551
    Abstract: A composition for treating insomnia and related disorders is disclosed. The composition may include: (i) at least one polar lipid comprising at least one poly-unsaturated fatty acid (PUFA) moiety and (ii) Cannabidiol (CBD) or a derivative thereof.
    Type: Application
    Filed: June 16, 2020
    Publication date: December 29, 2022
    Applicant: Vaxa Technologies Ltd.
    Inventors: Ohad BASHAN, Isaac BERZIN
  • Publication number: 20220354398
    Abstract: A device, system and method of non-invasive monitoring of physiological measurements of a subject are disclosed. The method may include: emitting light beams towards skin of the subject, with at least one light source having at least one predetermined polarization, wherein the light beams are emitted at an angle 0°???90° relative to the normal to the skin surface of the subject; sensing light beams with at least one light sensor positioned at a predetermined distance from the at least one light emitting source; filtering out signals corresponding to detected light beams based on the at least one predetermined polarization of the at least one light source; and determining at least one physiological signal, based on the sensed light beams after filtering. The sensed light beams may pass through at least one of epidermis, dermis, subcutaneous tissue and blood vessel of the subject.
    Type: Application
    Filed: July 24, 2022
    Publication date: November 10, 2022
    Applicant: Wear2B Ltd.
    Inventors: Ohad BASHAN, Giora Bar-Sakai, Oded Bashan, Ben Zion Dekel
  • Publication number: 20220322626
    Abstract: A method of growing algae in a cultivation container is disclosed. In some the method may include: circulating, via the cultivation container, in a closed loop, a first predetermined amount of gas mixture comprising a first type of gas and at least one second type of gas, the gas mixture may enter the container via one or more entrance spargers and exit via at least one exit pipe, the first type of gas may contain CO2 at a known first amount; receiving signal indicative of the amount of CO2 or H2S, in the gas mixture; when the signal indicates that the amount of CO2 drops below a first predetermined level or when the signal indicates that the amount of H2S rises above a first predetermined level, extracting a second predetermined amount of the gas mixture from the cultivation container: and adding an amount of the first type of gas to the gas mixture, equal to the second predetermined amount.
    Type: Application
    Filed: June 20, 2022
    Publication date: October 13, 2022
    Applicant: Vaxa Technologies Ltd.
    Inventors: Ohad BASHAN, Isaac BERZIN, Oded BASHAN
  • Publication number: 20220256884
    Abstract: Disclosed is a non-toxic omega-3 rich extract and non-toxic miscella and a method of producing same. The method may include obtaining an aqueous microalgae slurry comprising at least 65% water; mixing the aqueous microalgae slurry with ethanol for a predetermined duration; separating the aqueous microalgae slurry-ethanol mixture to liquids and miscella; and evaporating the water and the ethanol from the liquid to receive a liquid extract. In some embodiments, the miscella contains organic material and ash at an amount below 15 dry weight %.
    Type: Application
    Filed: May 27, 2020
    Publication date: August 18, 2022
    Applicant: Vaxa Technologies Ltd
    Inventors: Ohad BASHAN, Isaac BERZIN
  • Patent number: 11395610
    Abstract: A device, system and method of non-invasive monitoring of physiological measurements of a subject are disclosed. The method may include: emitting light beams towards skin of the subject, with at least one light source having at least one predetermined polarization, wherein the light beams are emitted at an angle 0°??<90° relative to the normal to the skin surface of the subject; sensing light beams with at least one light sensor positioned at a predetermined distance from the at least one light emitting source; filtering out signals corresponding to detected light beams based on the at least one predetermined polarization of the at least one light source; and determining at least one physiological signal, based on the sensed light beams after filtering. The sensed light beams may pass through at least one of epidermis, dermis, subcutaneous tissue and blood vessel of the subject.
    Type: Grant
    Filed: August 16, 2018
    Date of Patent: July 26, 2022
    Assignee: Wear2B Ltd.
    Inventors: Ohad Bashan, Giora Bar-Sakai, Oded Bashan, Ben Zion Dekel
  • Publication number: 20220225934
    Abstract: A wearable monitoring device is disclosed. The wearable monitoring device may include: a housing, opened from at least one side; a sensing unit attached to a movable plate; and a controller. The movable plate may be connected to one or more spring-like elements, allowing the movable plate to move with respect to the housing so that when the one or more spring-like elements are extended, the sensing unit protrudes from the open side of the housing and when the one or more spring-like elements are compressed the sensing unit and the movable plate are retracted towards an internal space in the housing.
    Type: Application
    Filed: May 27, 2020
    Publication date: July 21, 2022
    Applicant: Wear2B Ltd.
    Inventors: Ohad BASHAN, Giora BAR-SAKAI, Oded BASHAN
  • Publication number: 20220220411
    Abstract: A method of extracting Polyhydroxylated Fatty Alcohols is disclosed. The method may include: inserting crushed avocado seeds to one or more extraction chambers; flowing supercritical CO2 fluid through the crushed avocado seeds in one or more extraction chambers; and separating from the supercritical CO2 flown through the crushed avocado seeds the Polyhydroxylated Fatty Alcohols extracted and dissolved in the supercritical CO2. The supercritical CO2 fluid may be the only solvent used for dissolving and extracting the Polyhydroxylated Fatty Alcohols.
    Type: Application
    Filed: May 18, 2020
    Publication date: July 14, 2022
    Applicant: AVOMED LTD.
    Inventors: Yael DVORI LEVY, Oded BASHAN, Ohad BASHAN
  • Patent number: 11129556
    Abstract: System and method for non-invasive monitoring of physiological measurements of a subject, including at least one monitoring device, to detect changes in measured physiological signals, the monitoring device including at least one measuring unit, wherein each measuring unit includes: at least two light emitting sources, and at least one sensor, to detect light beams emitted from the at least two light emitting source, and a computerized device, in communication with the at least one monitoring device, the computerized device to receive data from monitoring device, wherein the monitoring device is configured to be removably attachable to the subject's body.
    Type: Grant
    Filed: December 28, 2016
    Date of Patent: September 28, 2021
    Assignee: WEAR2B LTD.
    Inventors: Ohad Bashan, Oded Bashan, Aharon Klein, Ben Zion Dekel
  • Publication number: 20210246404
    Abstract: A device for storing live algae is disclosed. The device may include: a closed container, at least partially transparent to light, the container is configured to hold live algae aquaculture at a predetermined temperature; at least one light source for providing light to the closed container; a CO2 source for providing CO2 to the closed container; an air circulation system for circulating air inside the closed container; and a controller for controlling the at least one light source to illuminate an internal space of the closed container in an amount sufficient to keep the algae aquaculture alive but inhibits reproduction of the algae for at least 4 weeks.
    Type: Application
    Filed: May 2, 2019
    Publication date: August 12, 2021
    Applicant: Vaxa Technologies Ltd.
    Inventors: Ohad BASHAN, Isaac BERZIN, Oded BASHAN, Sam C. COUTURE
  • Publication number: 20210179986
    Abstract: A method of growing algae in a cultivation container is disclosed. In some the method may include: circulating, via the cultivation container, in a closed loop, a first predetermined amount of gas mixture comprising a first type of gas and at least one second type of gas, the gas mixture may enter the container via one or more entrance spargers and exit via at least one exit pipe, the first type of gas may contain CO2 at a known first amount; receiving signal indicative of the amount of CO2, in the gas mixture; when the signal indicates that the amount of CO2 drops below a first predetermined level, extracting a second predetermined amount of the gas mixture from the cultivation container: and adding an amount of the first type of gas to the gas mixture, equal to the second predetermined amount.
    Type: Application
    Filed: November 5, 2018
    Publication date: June 17, 2021
    Applicant: Algaennovation Ltd.
    Inventors: Ohad BASHAN, Isaac BERZIN, Oded BASHAN
  • Publication number: 20200261005
    Abstract: A device, system and method of non-invasive monitoring of physiological measurements of a subject are disclosed. The method may include: emitting light beams towards skin of the subject, with at least one light source having at least one predetermined polarization, wherein the light beams are emitted at an angle 0°??<90° relative to the normal to the skin surface of the subject; sensing In light beams with at least one light sensor positioned at a predetermined distance from the at least one light emitting source; filtering out signals corresponding to detected light beams based on the at least one predetermined polarization of the at least one light source; and determining at least one physiological signal, based on the sensed light beams after filtering. The sensed light beams may pass through at least one of epidermis, dermis, subcutaneous tissue and blood vessel of the subject.
    Type: Application
    Filed: August 16, 2018
    Publication date: August 20, 2020
    Applicant: WEAR2B LTD.
    Inventors: Ohad Bashan, Giora Bar-Sakai, Oded Bashan, Ben Zion Dekel
  • Publication number: 20200231925
    Abstract: An algae cultivation system may include: a plurality of panels within a cultivation container, positioned along a first axis perpendicular to the gravitational force, wherein a cultivation volume is created between each pair of panels, and wherein the cultivation volumes are fluidly coupled so as to allow horizontal flow therebetween along the first axis; at least one first sparger, to distribute a first fluid into the container at a first operating flow rate; at least one second sparger, to distribute a second fluid into the container at a second operating flow rate; and at least one controller, to control the first operating flow rate and the second operating flow rate. The first operating flow rate may be adapted to allow turbulent mixing the algae in the cultivation container, and the second operating flow rate may be adapted to allow assimilation of materials in a liquid in the cultivation container.
    Type: Application
    Filed: February 20, 2018
    Publication date: July 23, 2020
    Applicant: Algaennovation LTD
    Inventors: Ohad BASHAN, Oded BASHAN, Stephen DRUMMEY
  • Publication number: 20200196918
    Abstract: A non-invasive monitoring device for monitoring physiological condition of a subject may include at least one light source for emitting light at at least one predetermined narrow spectral wavelength band onto a living tissue of the subject and two or more light sensors. Each of the two or more light sensors may correspond to a specific substance in a living tissue of the subject and may be configured to measure a change in a concentration of the specific substances to which the sensor corresponds. The distance of each of the two or more sensors from the light source, may be determined so that intensity of light scattered by each specific substance, may have a maximal signal to noise ratio at the determined distance of the corresponding sensor.
    Type: Application
    Filed: May 17, 2018
    Publication date: June 25, 2020
    Applicant: WEAR2B LTD.
    Inventors: MOTI ITZKOVICH, Ohad BASHAN, Giora BAR-SAKAI, Oded BASHAN
  • Publication number: 20200037933
    Abstract: A system for calibrating a device for measuring materials concentration in the blood is disclosed. The system may include at least two sets of calibrating elements, each set may include a plurality of calibrating elements. Each of the calibrating elements in the sets may include, a first layer simulating a specific human skin characteristics; and a second layer consisting a specific concentration of one or more materials in the blood. For all calibrating elements in a set the first layer may be the same first layer simulating the same human skin characteristics such that each set of calibrating elements simulate different skin characteristics. Each calibrating element in a set of calibrating elements may include a different second layer consisting a different concentration of the one or more materials. The system may further include a controller.
    Type: Application
    Filed: October 2, 2017
    Publication date: February 6, 2020
    Applicant: Wear2B Ltd.
    Inventors: Ohad BASHAN, Oded BASHAN, Aharon KLEIN, Ben Zion DEKEL, Giora BAR-SAKAI